Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
J Yang, H Guo, L Han, Y Song, K Zhou - Experimental Hematology & …, 2024 - Springer
Over the past few years, dual-targeted chimeric antigen receptor (CAR) T-cell therapy has
been employed in the management of hematological malignancies to mitigate treatment …
been employed in the management of hematological malignancies to mitigate treatment …